Hospital or health organisation · founded 1913
City of Hope
Lancaster, United States · cityofhope.org/location/antelope-valley
- Citations, last 5 years
- 83.9k
- Works, last 5 years
- 7 099
- h-index
- 595
- Scientists listed
- 0
- Grants since 2016
- 654
Grants received
2026 · grant
A novel viral and immunological approach to the treatment of glioblastoma
Michael A Caligiuri · City of Hope · funded by Uncle Kory Foundation
2026 · career development · Young Investigator Award
Targeting the Tumor Immune Microenvironment to Overcome BTK Inhibitor Resistance in Mantle Cell Lymphoma
Annie Xiao · City of Hope · funded by Conquer Cancer Foundation
2025 · research · PCF Young Investigator Award
Investigating a Novel Immunotherapeutic Targeting CEACAM5 in Androgen Indifferent Prostate Cancer
Charles Nguyen · City of Hope · funded by Prostate Cancer Foundation
2025–2030 · cooperative agreement · U01
Mechanism and therapeutic implication of RNA-modification-mediated codon-biased translation in acute myeloid leukemia
Jianjun Chen · City of Hope · funded by National Institutes of Health
2025–2027 · cooperative agreement · U24
PITT-CAL ETCTN PK Resource Laboratory
Timothy W Synold · City of Hope · funded by National Institutes of Health
2025–2030 · research · R01
Targeting Tumor-Associated Macrophages to Treat Lymphoma
Mingye Feng · City of Hope · funded by National Institutes of Health
2025–2030 · research · R01
Targeting AMP Synthesis to Overcome Resistance to BH3 Mimetics in Acute Myeloid Leukemia
Ling Li · City of Hope · funded by National Institutes of Health
2025–2027 · research · R03
Evaluating the ELF5 Clock as a Biomarker in Breast Cancer Prevention Trials
Masaru Miyano · City of Hope · funded by National Institutes of Health
2025–2030 · research · R37
The Role and Function of a Novel Signature Gene in BCR::ABL1 (Ph) B-cell Acute Lymphoblastic Leukemia
Zhaohui Gu · City of Hope · funded by National Institutes of Health
2025–2030 · research · R01
The role of IL-6/STAT3 signaling in CIC-DUX4 fusion sarcoma metastasis and immunosuppression
Ross Okimoto · City of Hope · funded by National Institutes of Health
2025–2030 · research · R01
Role of RNA modification in innate immune cell development and function
Shoubao Ma · City of Hope · funded by National Institutes of Health
2025–2030 · research · R01
Role of UPR transducer Xbp1 in Pancreatic Beta Cell Survival and Function under Metabolic Stress
Yingfeng Deng · City of Hope · funded by National Institutes of Health
2025–2030 · research · R01
Novel mechanisms and therapeutics for Tyrosine Kinase Inhibitor-induced Cardiotoxicity
June-Wha Rhee · City of Hope · funded by National Institutes of Health
2025–2030 · research · R01
Epigenetic regulation of genomic stability in beta-cell homeostasis
Sangeeta Dhawan · City of Hope · funded by National Institutes of Health
2024–2026 · research · R21
Developing a novel therapeutic strategy for overcoming resistance to PD-1 blockade in Triple-negative breast cancer
Chunyan Zhang · City of Hope · funded by National Institutes of Health
2024–2025 · research · R13
21st International Conference of the Society for Integrative Oncology
Richard T Lee · City of Hope · funded by National Institutes of Health
2024–2026 · research · R21
Concurrent eradication of pathogenic plasma cells and their precursors in systemic lupus erythematosus
Srividya Swaminathan · City of Hope · funded by National Institutes of Health
2024–2029 · cooperative agreement · U01
State-transition and leukemia potential dynamics to inform disease evolution and adaptive therapy
Ya-Huei Kuo · City of Hope · funded by National Institutes of Health
2024–2028 · research · R01
Integrative role of Rps6kb1 in pathological cardiac remodeling
Zhao Wang · City of Hope · funded by National Institutes of Health
2024–2025 · career development · K08
Multi-antigen-specific CAR T cells to treat acute myeloid leukemia
Scott E James · City of Hope · funded by National Institutes of Health
2024–2029 · research · R37
Examining the Impact of Structural Racism on African American Non-Small Cell Lung Cancer Mutational Signatures and Outcomes
Loretta Erhunmwunsee · City of Hope · funded by National Institutes of Health
2024–2029 · program · P01
Mucus-degrading intestinal bacteria and toxicities of hematopoietic cell transplantation
Robert Jenq · City of Hope · funded by National Institutes of Health
2024–2029 · research · R01
Biological function and regulation of PRMT9 in synapse development
Yanzhong Yang · City of Hope · funded by National Institutes of Health
2024–2029 · research · R37
The role, mechanism, and therapeutic potential of METTL1 in acute myeloid leukemia
Rui Su · City of Hope · funded by National Institutes of Health
2024–2029 · research · R50
Leading NCI Clinical Trials Network research nationally and at the City of Hope Comprehensive Cancer Center
Alex F. Herrera · City of Hope · funded by National Institutes of Health
2024–2028 · research · R01
Role of autoreactivity in pathogenesis of chronic graft versus host disease
Defu Zeng · City of Hope · funded by National Institutes of Health
2024–2025 · award
Combinatorial radiotherapy and CAR T cells targeting prostate stem cell antigen for metastatic prostate cancer
Rose Li · City of Hope · funded by American Cancer Society
2024–2025 · fellowship · F32
Development of novel CYP8B1 inhibitors
Alon Roy Llagas Agua · City of Hope · funded by National Institutes of Health
2024–2026 · research · R01
Elucidating the role of DNAPKcs in chromosomal break end joining and clastogen
Jeremy Michael Stark · City of Hope · funded by National Institutes of Health
2024–2028 · research · R01
Integrative role of Rps6kb1 in pathological cardiac remodeling
Zhao Wang · City of Hope · funded by National Institutes of Health
2024–2027 · research · R21
Developing a novel therapeutic strategy for overcoming resistance to PD-1 blockade in Triple-negative breast cancer
Chunyan Zhang · City of Hope · funded by National Institutes of Health
2024–2029 · research · R25
Cancer Aging and Metabolism research experience Program (CAMP)
David K. Ann · City of Hope · funded by National Institutes of Health
2024–2029 · research · R01
Attacking the Tumor Cell-Immune Milieu Interface to Overcome Richter's Transformation
Alexey V. Danilov · City of Hope · funded by National Institutes of Health
2024–2029 · program · P01
Mucus-degrading intestinal bacteria and toxicities of hematopoietic cell transplantation
Robert Jenq · City of Hope · funded by National Institutes of Health
2024–2029 · program · P01
Mucus-degrading intestinal bacteria and toxicities of hematopoietic cell transplantation
Robert Jenq · City of Hope · funded by National Institutes of Health
2024–2029 · research · R37
Air Pollution and Neighborhood Stressors as Determinants of Non-Small Cell Lung Cancer (NSCLC) Mutation Patterns and Recurrence
Loretta Erhunmwunsee · City of Hope · funded by National Institutes of Health
2024–2026 · research · R21
Non-receptor protein tyrosine phosphatases in macrophage-mediated cancer cell phagocytosis.
Mingye Feng · City of Hope · funded by National Institutes of Health
2024–2029 · research · R01
Targeting mitochondrial RNA methylation in high-risk acute myeloid leukemia
Rui Su · City of Hope · funded by National Institutes of Health
2024–2029 · research · R01
Biological function and regulation of PRMT9 in synapse development
Yanzhong Yang · City of Hope · funded by National Institutes of Health
2024–2029 · cooperative agreement · U01
State-transition and leukemia potential dynamics to inform disease evolution and adaptive therapy
Ya-Huei Kuo · City of Hope · funded by National Institutes of Health